MedPath

Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus

Phase 3
Completed
Conditions
Diabetes Mellitus, Type 2
Obesity
Interventions
Drug: Placebo
Drug: BI 10773
Registration Number
NCT01306214
Lead Sponsor
Boehringer Ingelheim
Brief Summary

This trial will evaluate use of BI 10773 as add-on to insulin regimen alone or with metformin in patients with typr 2 diabetes. Both lowering glucose and HbA1c and reducing the use of insulin in this population would provide significant new information for the BI 10773 use and would offer a potential new therapeutic option in this population.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
566
Inclusion Criteria

Not provided

Read More
Exclusion Criteria

Not provided

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
BI 10773 low dosePlaceboBI 10773 low dose once daily
BI 10773 low doseBI 10773BI 10773 low dose once daily
BI 10773 high dosePlaceboBI 10733 high dose once daily
BI 10773 high doseBI 10773BI 10733 high dose once daily
PlaceboPlaceboPlacebo tablets matching BI 10773
Primary Outcome Measures
NameTimeMethod
Change From Baseline in HbA1c After 18 Weeks of TreatmentBaseline and 18 weeks

The primary endpoint was the change from baseline in HbA1c after 18 weeks of treatment.

Secondary Outcome Measures
NameTimeMethod
Change From Baseline in Insulin Dose After 52 Weeks of TreatmentBaseline and 52 weeks

The secondary endpoint is change from baseline in insulin dose after 52 weeks of treatment

Change From Baseline in Body Weight After 52 Weeks of TreatmentBaseline and 52 weeks

The secondary endpoint was the change from baseline in body weight after 52 weeks of treatment

Change From Baseline in HbA1c After 52 Weeks of TreatmentBaseline and 52 weeks

The secondary endpoint was the change from baseline in HbA1c after 52 weeks of treatment

Trial Locations

Locations (103)

1245.49.10019 Boehringer Ingelheim Investigational Site

🇺🇸

Westlake Village, California, United States

1245.49.10007 Boehringer Ingelheim Investigational Site

🇺🇸

Fargo, North Dakota, United States

1245.49.10015 Boehringer Ingelheim Investigational Site

🇺🇸

Evansville, Indiana, United States

1245.49.10033 Boehringer Ingelheim Investigational Site

🇺🇸

Bountiful, Utah, United States

1245.49.32010 Boehringer Ingelheim Investigational Site

🇧🇪

Bonheiden, Belgium

1245.49.34016 Boehringer Ingelheim Investigational Site

🇪🇸

Santiago de Compostela (La Coruña), Spain

1245.49.49002 Boehringer Ingelheim Investigational Site

🇩🇪

Neuwied, Germany

1245.49.49005 Boehringer Ingelheim Investigational Site

🇩🇪

Saarbrücken, Germany

1245.49.75016 Boehringer Ingelheim Investigational Site

🇺🇦

Kharkov, Ukraine

1245.49.75014 Boehringer Ingelheim Investigational Site

🇺🇦

Kiev, Ukraine

1245.49.34044 Boehringer Ingelheim Investigational Site

🇪🇸

Madrid, Spain

1245.49.42010 Boehringer Ingelheim Investigational Site

🇨🇿

Brno, Czech Republic

1245.49.10011 Boehringer Ingelheim Investigational Site

🇺🇸

Chandler, Arizona, United States

1245.49.10002 Boehringer Ingelheim Investigational Site

🇺🇸

Corona, California, United States

1245.49.10013 Boehringer Ingelheim Investigational Site

🇺🇸

El Cajon, California, United States

1245.49.10030 Boehringer Ingelheim Investigational Site

🇺🇸

Lomita, California, United States

1245.49.10025 Boehringer Ingelheim Investigational Site

🇺🇸

Greer, South Carolina, United States

1245.49.10022 Boehringer Ingelheim Investigational Site

🇺🇸

Memphis, Tennessee, United States

1245.49.10020 Boehringer Ingelheim Investigational Site

🇺🇸

Renton, Washington, United States

1245.49.10026 Boehringer Ingelheim Investigational Site

🇺🇸

Norfolk, Virginia, United States

1245.49.32002 Boehringer Ingelheim Investigational Site

🇧🇪

Edegem, Belgium

1245.49.59004 Boehringer Ingelheim Investigational Site

🇧🇬

Sofia, Bulgaria

1245.49.59003 Boehringer Ingelheim Investigational Site

🇧🇬

Pleven, Bulgaria

1245.49.57003 Boehringer Ingelheim Investigational Site

🇨🇴

Barranquilla, Colombia

1245.49.59001 Boehringer Ingelheim Investigational Site

🇧🇬

Stara Zagora, Bulgaria

1245.49.57004 Boehringer Ingelheim Investigational Site

🇨🇴

Bogotá, Colombia

1245.49.57005 Boehringer Ingelheim Investigational Site

🇨🇴

Bogota, Colombia

1245.49.42013 Boehringer Ingelheim Investigational Site

🇨🇿

Breclav, Czech Republic

1245.49.42003 Boehringer Ingelheim Investigational Site

🇨🇿

Brno, Czech Republic

1245.49.42011 Boehringer Ingelheim Investigational Site

🇨🇿

Chrudim, Czech Republic

1245.49.33011 Boehringer Ingelheim Investigational Site

🇫🇷

Le Creusot, France

1245.49.33001 Boehringer Ingelheim Investigational Site

🇫🇷

Grenoble Cedex, France

1245.49.33010 Boehringer Ingelheim Investigational Site

🇫🇷

Narbonne Cedex, France

1245.49.33003 Boehringer Ingelheim Investigational Site

🇫🇷

Nantes cedex 1, France

1245.49.33012 Boehringer Ingelheim Investigational Site

🇫🇷

Marseille, France

1245.49.33007 Boehringer Ingelheim Investigational Site

🇫🇷

Point-à-Pitre Cedex, France

1245.49.33004 Boehringer Ingelheim Investigational Site

🇫🇷

Pierre Benite, France

1245.49.33008 Boehringer Ingelheim Investigational Site

🇫🇷

Saint Priest en Jarez, France

1245.49.49104 Boehringer Ingelheim Investigational Site

🇩🇪

Bosenheim, Germany

1245.49.49013 Boehringer Ingelheim Investigational Site

🇩🇪

Dresden, Germany

1245.49.33009 Boehringer Ingelheim Investigational Site

🇫🇷

Vénissieux Cedex, France

1245.49.49101 Boehringer Ingelheim Investigational Site

🇩🇪

Mainz, Germany

1245.49.49102 Boehringer Ingelheim Investigational Site

🇩🇪

Wangen, Germany

1245.49.50201 Boehringer Ingelheim Investigational Site

🇬🇹

Guatemala, Guatemala

1245.49.50202 Boehringer Ingelheim Investigational Site

🇬🇹

Guatemala, Guatemala

1245.49.50204 Boehringer Ingelheim Investigational Site

🇬🇹

Guatemala, Guatemala

1245.49.50205 Boehringer Ingelheim Investigational Site

🇬🇹

Quetzaltenango, Guatemala

1245.49.52003 Boehringer Ingelheim Investigational Site

🇲🇽

Durango, Mexico

1245.49.52012 Boehringer Ingelheim Investigational Site

🇲🇽

Cuautla, Mexico

1245.49.52004 Boehringer Ingelheim Investigational Site

🇲🇽

Guadalajara, Mexico

1245.49.52005 Boehringer Ingelheim Investigational Site

🇲🇽

Durango, Mexico

1245.49.52006 Boehringer Ingelheim Investigational Site

🇲🇽

Guadalajara, Mexico

1245.49.52002 Boehringer Ingelheim Investigational Site

🇲🇽

Monterrey, Mexico

1245.49.52009 Boehringer Ingelheim Investigational Site

🇲🇽

Monterrey, Mexico

1245.49.51006 Boehringer Ingelheim Investigational Site

🇵🇪

Arequipa, Peru

1245.49.51002 Boehringer Ingelheim Investigational Site

🇵🇪

Arequipa, Peru

1245.49.52001 Boehringer Ingelheim Investigational Site

🇲🇽

México, D.F., Mexico

1245.49.51010 Boehringer Ingelheim Investigational Site

🇵🇪

Jesus Maria, Peru

1245.49.70008 Boehringer Ingelheim Investigational Site

🇷🇺

Moscow, Russian Federation

1245.49.70006 Boehringer Ingelheim Investigational Site

🇷🇺

St. Petersburg, Russian Federation

1245.49.70009 Boehringer Ingelheim Investigational Site

🇷🇺

Moscow, Russian Federation

1245.49.51009 Boehringer Ingelheim Investigational Site

🇵🇪

Lima, Peru

1245.49.51008 Boehringer Ingelheim Investigational Site

🇵🇪

Lima, Peru

1245.49.34039 Boehringer Ingelheim Investigational Site

🇪🇸

Avila, Spain

1245.49.34038 Boehringer Ingelheim Investigational Site

🇪🇸

Madrid, Spain

1245.49.34047 Boehringer Ingelheim Investigational Site

🇪🇸

Palma de Mallorca, Spain

1245.49.34043 Boehringer Ingelheim Investigational Site

🇪🇸

MBoadilla del Monte (Madrid), Spain

1245.49.34045 Boehringer Ingelheim Investigational Site

🇪🇸

pozuelo de Alarcon, Spain

1245.49.75007 Boehringer Ingelheim Investigational Site

🇺🇦

Kiev, Ukraine

1245.49.34041 Boehringer Ingelheim Investigational Site

🇪🇸

Valencia, Spain

1245.49.10014 Boehringer Ingelheim Investigational Site

🇺🇸

Spring Valley, California, United States

1245.49.32013 Boehringer Ingelheim Investigational Site

🇧🇪

La Louvière, Belgium

1245.49.32012 Boehringer Ingelheim Investigational Site

🇧🇪

Leuven, Belgium

1245.49.57006 Boehringer Ingelheim Investigational Site

🇨🇴

Bogota, Colombia

1245.49.52011 Boehringer Ingelheim Investigational Site

🇲🇽

Aguascalientes, Mexico

1245.49.52008 Boehringer Ingelheim Investigational Site

🇲🇽

Guadalajara, Mexico

1245.49.57002 Boehringer Ingelheim Investigational Site

🇨🇴

Medellín, Colombia

1245.49.42009 Boehringer Ingelheim Investigational Site

🇨🇿

Hodonin, Czech Republic

1245.49.72002 Boehringer Ingelheim Investigational Site

🇫🇮

Oulu, Finland

1245.49.50203 Boehringer Ingelheim Investigational Site

🇬🇹

Guatemala, Guatemala

1245.49.75015 Boehringer Ingelheim Investigational Site

🇺🇦

Kiev, Ukraine

1245.49.32007 Boehringer Ingelheim Investigational Site

🇧🇪

Huy, Belgium

1245.49.42012 Boehringer Ingelheim Investigational Site

🇨🇿

Svitavy56802, Czech Republic

1245.49.10004 Boehringer Ingelheim Investigational Site

🇺🇸

Tucson, Arizona, United States

1245.49.72003 Boehringer Ingelheim Investigational Site

🇫🇮

Turku, Finland

1245.49.52010 Boehringer Ingelheim Investigational Site

🇲🇽

Monterrey, Mexico

1245.49.32014 Boehringer Ingelheim Investigational Site

🇧🇪

Jette, Belgium

1245.49.72001 Boehringer Ingelheim Investigational Site

🇫🇮

Kuopio, Finland

1245.49.51001 Boehringer Ingelheim Investigational Site

🇵🇪

Lima, Peru

1245.49.70010 Boehringer Ingelheim Investigational Site

🇷🇺

St. Petersburg, Russian Federation

1245.49.75013 Boehringer Ingelheim Investigational Site

🇺🇦

Kyiv, Ukraine

1245.49.10021 Boehringer Ingelheim Investigational Site

🇺🇸

Blue Ridge, Georgia, United States

1245.49.10009 Boehringer Ingelheim Investigational Site

🇺🇸

Chicago, Illinois, United States

1245.49.10003 Boehringer Ingelheim Investigational Site

🇺🇸

Austin, Texas, United States

1245.49.10001 Boehringer Ingelheim Investigational Site

🇺🇸

Dallas, Texas, United States

1245.49.10031 Boehringer Ingelheim Investigational Site

🇺🇸

Houston, Texas, United States

1245.49.10006 Boehringer Ingelheim Investigational Site

🇺🇸

Columbus, Ohio, United States

1245.49.10005 Boehringer Ingelheim Investigational Site

🇺🇸

Birmingham, Alabama, United States

1245.49.10016 Boehringer Ingelheim Investigational Site

🇺🇸

Miami, Florida, United States

1245.49.10024 Boehringer Ingelheim Investigational Site

🇺🇸

Denver, Colorado, United States

1245.49.10018 Boehringer Ingelheim Investigational Site

🇺🇸

Hialeah, Florida, United States

1245.49.10023 Boehringer Ingelheim Investigational Site

🇺🇸

Greenville, North Carolina, United States

1245.49.10032 Boehringer Ingelheim Investigational Site

🇺🇸

Salt Lake City, Utah, United States

© Copyright 2025. All Rights Reserved by MedPath